We previously found that endogenous IL-4 inhibits tumor growth of MCA205 fibrosarcoma by promoting MDSC differentiation into DCs [26], [27], while IL-4 has no effect on late stage tumor growth owing to down-regulation of surface IL-4 receptors on MDSCs [23]. The gene discussed is IL4; the disease is fibrosarcoma.